GHK-CU vs BPC-157 BPC-157 focuses on gut healing and connective tissue repair through nitric oxide pathways
Molecular changes in the GSH antioxidant system and disturbances in GSH homeostasis have been implicated in tumor initiation, progression, and treatment response
During our review process, we also evaluated several commercially available GHK-Cu products and research-grade suppliers, including Koi Peptides, for formulation transparency, purity testing, and manufacturing standards
Availability: In stock GLOW Blend 70mg (GHK-Cu / BPC-157 / TB-500) The GLOW Blend combines three synthetic peptides GHK-Cu, BPC-157, and Thymosin Beta 4 (TB-500) into a single lyophilized formulation supplied for in vitro and in vivo (animal) laboratory research
Dalmasso et al
Compound-level evidence does not automatically validate the blend